IL13 receptor alpha 1 Recombinant Antbody Kit (KD-Validated)
Applications
Reactivity
| Overview | |
| Catalog # | bsm-90271r-50uL |
| Product Name | IL13 receptor alpha 1 Recombinant Antbody Kit (KD-Validated) |
| Applications |
WB
FCM
IC
|
| Specificity | Knockdown Validated |
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | A synthesized peptide derived from human IL13 receptor alpha 1 |
| Immunogen Range | 50-101/427 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Affinity Purified |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | -20°C |
| Target | |
| Gene ID | 3597 |
| Swiss Prot | P78552 |
| Synonyms | IL13RA1; Interleukin 13 Receptor Subunit Alpha 1; CD213a1 Antigen; IL-13Ra; CD213a1; NR4; Interleukin-13 Receptor Subunit Alpha-1; Interleukin 13 Receptor Alpha 1; IL-13 Receptor Subunit Alpha-1; IL13 Receptor Alpha-1 Chain; Cancer/Testis Antigen 19; IL-13R Subunit Alpha-1; CT19; IL-13R-Alpha-1; IL-13RA1; IL13RA; IL13R |
| Background | Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution | |
| WB | 1:300-5000 |
| FCM | 1:20-100 |
| IC | 1:1000 |